Kiri Granger
Affiliations: | University of Nottingham, Nottingham, England, United Kingdom |
Google:
"Kiri Granger"Mean distance: 18.29 (cluster 17)
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Dawes C, Quinn D, Bickerdike A, et al. (2022) Latent inhibition, aberrant salience, and schizotypy traits in cannabis users. Schizophrenia Research. Cognition. 28: 100235 |
Granger KT, Ferrar J, Caswell S, et al. (2021) Effects of 7.5% Carbon Dioxide and Nicotine Administration on Latent Inhibition. Frontiers in Psychiatry. 12: 582745 |
Cotter J, Barnett JH, Granger K. (2019) The Use of Cognitive Screening in Pharmacotherapy Trials for Cognitive Impairment Associated With Schizophrenia. Frontiers in Psychiatry. 10: 648 |
Granger K, Cotter J, Baker E, et al. (2019) 32.3 A Post-Hoc Analysis Exploring Participant-Level Trajectories Of Cognitive Performance Among Patients With Schizophrenia In A Multi-National Phase Ii Trial Schizophrenia Bulletin. 45 |
Barnett J, Ferrar J, Rejon CS, et al. (2019) O10.4. Latent Inhibition As A Stratification Tool For Schizophrenia Drug Development Schizophrenia Bulletin. 45 |
Granger K, Martyn Q, Ryan L, et al. (2019) F34. ASSOCIATIVE LEARNING ABNORMALITIES IN PSYCHOSIS Schizophrenia Bulletin. 45: S268-S268 |
Cotter J, Muhlert N, Talwar A, et al. (2018) Examining the effectiveness of acetylcholinesterase inhibitors and stimulant-based medications for cognitive dysfunction in multiple sclerosis: A systematic review and meta-analysis. Neuroscience and Biobehavioral Reviews. 86: 99-107 |
Cotter J, Granger K, Backx R, et al. (2018) Social cognitive dysfunction as a clinical marker: A systematic review of meta-analyses across 30 clinical conditions. Neuroscience and Biobehavioral Reviews. 84: 92-99 |
Cotter J, Granger K, Backx R, et al. (2018) Social cognitive dysfunction as a clinical marker: A systematic review of meta-analyses across 30 clinical conditions. Neuroscience and Biobehavioral Reviews. 84: 92-99 |
Granger K, Cotter J, Baker E, et al. (2018) S74. Exploring Participant-Level Trajectories Of Cognitive Performance Among Patients With Schizophrenia In A Multi-National Trial. Schizophrenia Bulletin. 44 |